Among 526 specimens tested using NGS, the prevalence of ALK and KRAS mutations in NSCLC patients from Qujing and non-Qujing areas was as similar as the results by ARMS-PCR (Supplementary Table 3). Here, KRAS is linked to non-small cell lung carcinoma.